Sanofi

30 Mar 2021

Sanofi launches game-changing TB prevention treatment in SA

By Staff Writer

TB can affect anyone, anywhere – but it is also curable and preventable.1 b,c World TB Day falls on 24 March, and Sanofi, in partnership with the Department of Health, has launched an innovative TB prevention treatment called 3HP which is set to be a game changer for the South African market. TB remains a...

09 Nov 2020

Sanofi awarded by ISPE for its Facility of the Future

By Staff Writer

The International Society for Pharmaceutical Engineering (ISPE) announced Sanofi as the 2020 Facility of the Year Awards (FOYA) Overall Winner at the 2020 FOYA Banquet during the virtual 2020 ISPE Annual Meeting & Expo. Sanofi was awarded the 2020 FOYA Facility of the Future Category Award in April 2020 for its Sanofi Digitally Enabled Integrated...

10 Sep 2018

Sanofi bets big on India

By Staff Writer

Sanofi Genzyme, the specialty care global business unit of French multinational pharma company Sanofi, has recently launched its multiple sclerosis (MS) drug Aubagio (teriflunomide, 14 mg) in India. However, the company needs to be wary of the fierce generic competition and cost sensitivity of the Indian market, cautions leading data and analytics company GlobalData.

Visit the official COVID-19 government website to stay informed: sacoronavirus.co.za